Description
| Item ID # | 35578900 |
| Manufacturer # | 333557 |
| Brand | |
Features
- LifeShield™ Abboject™ glass syringe
- 18 gauge X 3-1/2 inch needle
- Protect from light
Alpha- and Beta-Adrenergic Agonist Epinephrine, Preservative Free 0.1 mg / mL, 1:10,000 Injection Prefilled Syringe 10 mL
UOM PACK/10
$156.31
Features
- LifeShield™ Abboject™ glass syringe
- 18 gauge X 3-1/2 inch needle
- Protect from light
10000 in stock
Related products
-
#61408900 Mfr# 2017226Bone Resorption Inhibitor Zoledronic Acid 5 mg / 100 mL Ready to Use Intravenous Injection Infusion Bottle 100 mL
Features
- Ready-to-use formulation
- Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy, multiple myeloma and bone metastases from solid tumors
- The zoledronic acid injection infusion time must not be less than 15 minutes given over a constant infusion rate
-
#58198900 Mfr#Fluarix® Quadrivalent Flu Vaccine 60 mcg / 0.5 mL Users 3 Years and Older Prefilled Syringe 0.5 mL
Features
- FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
- FLUARIX QUADRIVALENT is approved for use in persons 3 years of age and older
-
#58908900 Mfr# 589-05Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
- Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
- Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
-
#40988900 Mfr# 1107424Nitrostat® Nitrate Nitroglycerin 0.4 mg Sublingual Tablet Bottle 25 Tablets
Features
- NITROSTAT is a stabilized sublingual compressed nitroglycerin tablet
- The principal pharmacological action of nitroglycerin is relaxation of vascular smooth muscle
- Although venous effects predominate, nitroglycerin produces, in a dose-related manner, dilation of both arterial and venous beds